Literature DB >> 864771

Pattern of organ involvement in Burkitt's lymphoma in Ibadan: a review.

J I Durodola.   

Abstract

A retrospective study was conducted on 127 patients with Burkitt's lymphoma who had partial or complete records of both clinical and pathologic features of their disease. An analysis and description of the anatomical tumor distribution based on post-mortem examinations was made, highlighting lack of correlation between clinical staging and pathologic findings. A consistent observation was the high incidence of involvement of the kidney, liver, and heart in each of the stages (I-III).The data to be presented will clarify at least in part, the unpredictability of response of Burkitt's lymphoma patients to chemotherapeutic agents, because total cell-kill, needed for cure and/or prevention of relapse, is made almost impossible due to the widespread tumor volume carried by the patients.Effective supportive treatment might be a life-saving adjuvant regimen in treatment of Burkitt's lymphoma patients, where the organs so commonly involved might fail to function.

Entities:  

Mesh:

Year:  1977        PMID: 864771      PMCID: PMC2536962     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  A sarcoma involving the jaws in African children.

Authors:  D BURKITT
Journal:  Br J Surg       Date:  1958-11       Impact factor: 6.939

2.  Prevalence of cardiac tumours at autopsy in Ibadan.

Authors:  A A Abioye; I M Maolomo
Journal:  Trop Geogr Med       Date:  1975-03

3.  Burkitt's lymphoma in Ibadan: response to various chemotherapeutic agents and long-term survivors.

Authors:  J I Durodola
Journal:  J Natl Med Assoc       Date:  1976-07       Impact factor: 1.798

4.  Malignant Lymphoma: A Clinico-Pathologic Survey of 618 Cases.

Authors:  E A Gall; T B Mallory
Journal:  Am J Pathol       Date:  1942-05       Impact factor: 4.307

5.  Burkitt's lymphoma in Ibadan: response to various doses of cyclophosphamide and long-term survivors.

Authors:  J I Durodola
Journal:  Eur J Cancer       Date:  1976-06       Impact factor: 9.162

6.  Causes of death in patients with burkitt's lymphoma--the role of supportive care in overall management.

Authors:  I T Magrath; C Semawere; J Nkwocha
Journal:  East Afr Med J       Date:  1974-09

7.  Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas.

Authors:  D R Goffinet; R A Castellino; H Kim; R F Dorfman; Z Fuks; S A Rosenberg; T Nelsen; H S Kaplan
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

8.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

9.  The valve of exploratory laparotomy in malignant lymphoma.

Authors:  A C Hass; S F Brunk; H P Gulesserian; R L Givler
Journal:  Radiology       Date:  1971-10       Impact factor: 11.105

10.  Evidence for an orderly progression in the spread of Hodgkin's disease.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

View more
  2 in total

1.  Pattern of leukocyte counts in untreated Burkitt's lymphoma patients in Ibadan.

Authors:  J I Durodola
Journal:  J Natl Med Assoc       Date:  1977-12       Impact factor: 1.798

2.  Pattern of hemoglobin concentration in untreated Burkitt lymphoma patients in Ibadan.

Authors:  J I Durodola
Journal:  J Natl Med Assoc       Date:  1979-06       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.